Gehrke, Jason M
Cervantes, Oliver
Clement, M Kendell http://orcid.org/0000-0003-3808-0811
Wu, Yuxuan
Zeng, Jing
Bauer, Daniel E
Pinello, Luca
Joung, J Keith
Article History
Received: 28 February 2018
Accepted: 25 June 2018
First Online: 30 July 2018
Competing interests
: J.M.G. is currently a full-time employee of and holds equity in Beam Therapeutics. J.K.J. has financial interests in Beam Therapeutics, Editas Medicine, Monitor Biotechnologies, Pairwise Plants, Poseida Therapeutics, and Transposagen Biopharmaceuticals. J.K.J. holds equity in Endcadia, Inc. J.K.J.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. J.M.G. and J.K.J. are inventors on a patent application that has been filed for engineered sequence-specific deaminase domains in base editor architectures.